AbCellera Biologics Inc. logo

AbCellera Biologics Inc.

ABCL • NASDAQ

AbCellera Biologics Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Carl Hansen, with a market cap of $991.3M.

Market Cap$991.3M
Employees586.0
CEOCarl Hansen
CountryCanada
Healthcare
Biotechnology
Next EarningsMay 11, 2026 · in a monthQ1 2026
Income StatementBalance SheetCash FlowBusiness Segments

Financials

View all metrics

Revenue

View metric

Net Income

View metric

Operating Cash Flow

View metric

EPS (Diluted)

View metric
AbCellera Biologics Inc. logo

AbCellera Biologics Inc. FAQ

Common questions about AbCellera Biologics Inc.

AbCellera Biologics Inc. is scheduled to report earnings for Q1 2026 on May 11, 2026. Analysts estimate revenue of $5.7M.

AbCellera Biologics Inc. has approximately 586 employees.

Cookie Preferences

We use cookies for analytics. See our Privacy and Cookie Policy.